{"id":76102,"date":"2013-04-13T13:55:16","date_gmt":"2013-04-13T17:55:16","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/modernizing-medicines-electronic-medical-assistantr-ranks-first-among-specialty-specific-ehrs-for-dermatologists.php"},"modified":"2013-04-13T13:55:16","modified_gmt":"2013-04-13T17:55:16","slug":"modernizing-medicines-electronic-medical-assistantr-ranks-first-among-specialty-specific-ehrs-for-dermatologists","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/modernizing-medicines-electronic-medical-assistantr-ranks-first-among-specialty-specific-ehrs-for-dermatologists.php","title":{"rendered":"Modernizing Medicine&#39;s Electronic Medical Assistant(R) Ranks First Among Specialty Specific EHRs for Dermatologists &#8230;"},"content":{"rendered":"<p><p>    BOCA RATON, FL--(Marketwired - Apr 11, 2013) -     Modernizing Medicine, the creator of the Electronic Medical    Assistant (EMA), a cloud-based, specialty-specific,    electronic health records (EHR) system, announced today that    EMA Dermatology had the highest number of dermatologists    successfully attest for Meaningful Use among dermatology    specific EHR systems for the 2012 attestation year. Based on    numbers from the Office of the National Coordinator for Health    Information Technology (ONC), as of January 2013, a total of    362 dermatologists successfully attested using EMA Dermatology,    Modernizing Medicine's CCHIT Certified dermatology specific EHR    system.  <\/p>\n<p>    The ONC, along with the Center for Medicare and Medicaid    Services (CMS), recently compiled a     list of Electronic Health Record (EHR) systems used for the    attestation of Meaningful Use under the CMS Medicare and    Medicaid EHR Incentive Programs. These programs provide a    financial incentive for physicians that demonstrate they are    \"meaningfully using\" certified EHR technology by meeting    thresholds for certain objectives established by CMS. For    physicians who want to attest for Meaningful Use in 2013 and    earn their incentive payments, now is the time to implement an    EHR system.  <\/p>\n<p>    \"EMA, which received CCHIT certification in February 2012, did    not have any attestations prior to August 2012,\" said Michael    Sherling, MD, Chief Medical Officer and co-founder of    Modernizing Medicine. \"For successful attestations using EMA    from August 2012 to December 2012, an estimated $6.5 million in    Meaningful Use incentive dollars will be distributed. We're    thrilled to have helped those physicians earn their    well-deserved dollars and honored to have them as customers.\"  <\/p>\n<p>    \"Our five-physician practice attested for Meaningful Use in    2012,\" said Dr. Jonathan Weiss, a dermatologist with Gwinnett    Dermatology in Snellville, Georgia. \"By doing our documentation    with EMA Dermatology, it was easy for us to attain it. The    system kept track of the parameters, and it turned out to be a    simple process. Any physician who attests for the first time in    2013 can earn a $15,000 rebate from the government. As long as    they learn and follow the guidelines, they should be able to    easily obtain it with EMA.\"  <\/p>\n<p>    Many physicians using Modernizing Medicine's other    specialty-specific EHR systems, including EMA Ophthalmology    and EMA Optometry, have also successfully attested for    Meaningful Use. Providers must demonstrate Meaningful Use every    year to receive incentive payments, and the sooner physicians    attest in 2013 the sooner CMS will provide payment. For more    information visit     <a href=\"http:\/\/www.healthit.gov\" rel=\"nofollow\">http:\/\/www.healthit.gov<\/a>.  <\/p>\n<p>    Since launching in 2010, Modernizing Medicine has expanded to    save over 2,100 providers' time and money with EMA, including    over 14% of the dermatology market. For more information please    visit     <a href=\"http:\/\/www.modmed.com\" rel=\"nofollow\">http:\/\/www.modmed.com<\/a>.  <\/p>\n<p>    About Modernizing MedicineModernizing    Medicine is delivering the next generation of electronic health    records (EHR) technology for the healthcare industry. Our    product, Electronic Medical Assistant (EMA), is a cloud-based    specialty-specific EHR with a massive library of built-in    medical content, designed to save physicians time. Available as    a native iPad application or from any web-enabled Mac or PC,    EMA adapts to each provider's unique style of practice and is    designed to interface with hundreds of different practice    management systems. Today, Modernizing Medicine provides    specialty-specific offerings for the dermatology,    ophthalmology, optometry, orthopedics and plastic surgery    markets, and to more than 800 physician practices across the    country. In 2013 Modernizing Medicine was listed at No. 47 on    FORBES annual ranking of America's Most Promising Companies.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>More: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/modernizing-medicines-electronic-medical-assistant-130000605.html;_ylt=A2KJ3Cfqm2lRLDUAcRb_wgt.\" title=\"Modernizing Medicine&#39;s Electronic Medical Assistant(R) Ranks First Among Specialty Specific EHRs for Dermatologists ...\">Modernizing Medicine&#39;s Electronic Medical Assistant(R) Ranks First Among Specialty Specific EHRs for Dermatologists ...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> BOCA RATON, FL--(Marketwired - Apr 11, 2013) - Modernizing Medicine, the creator of the Electronic Medical Assistant (EMA), a cloud-based, specialty-specific, electronic health records (EHR) system, announced today that EMA Dermatology had the highest number of dermatologists successfully attest for Meaningful Use among dermatology specific EHR systems for the 2012 attestation year.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/modernizing-medicines-electronic-medical-assistantr-ranks-first-among-specialty-specific-ehrs-for-dermatologists.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[35],"tags":[],"class_list":["post-76102","post","type-post","status-publish","format-standard","hentry","category-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/76102"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=76102"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/76102\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=76102"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=76102"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=76102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}